The current valuation score of ADMA Biologics Inc is 7.29, ranking 112 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 12.16, which is 1002.61% below the recent high of 134.13 and 5295.20% above the recent low of -632.00.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.